Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of oral ladarixin in new-onset type 1 diabetes mellitus
2014-003968-20Phase 2Completed
- Sponsor
- Dompé
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Ladarixin 400 mg twice daily with Placebo (2 arms). Primary endpoint: Efficacy endpoint. Started Jun 2015; status: completed.
02
Drugs
ladarixin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-003968-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003968-20.